RoosterBio

Accelerating MSC & Exosome Product & Process Development

At RoosterBio, we are experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies.

Ushering in the Dawn of a New Day: We solve advanced therapy product and process development challenges with innovative biomanufacturing strategies.

RoosterBio works side-by-side with cell therapists, tissue engineers, product developers, and synthetic biologists to advance research and therapies across the globe. We partner our product portfolio, manufacturing expertise, and thorough characterization skills with our collaborators to reach your end goal

Occasionally companies are born that employ people who tackle something different — something that transcends the usual beliefs about the economy and business that has the chance to create new opportunities for millions. That’s what we’re building at RoosterBio.

If you have a genuine passion for helping invent the future of cell-based technologies, we invite you to apply.

Tim  Kelly

Tim Kelly

  • Chief Executive Officer (CEO)
Jon A.  Rowley

Jon A. Rowley

  • CPO: Chief Product Officer
  • Founder
Kathy  Williams

Kathy Williams

  • Vice President, Quality Assurance & Regulatory Affairs
Matt  Drew

Matt Drew

  • Chief Business Officer (CBO)
Chien-Chien  Jacques

Chien-Chien Jacques

  • CFO: Chief Financial Officer